Type 2 & other diabetes

CT-derived fractional flow reserve for prediction of major adverse cardiovascular events in diabetic patients

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

CT-FFR was a strong independent predictor for MACE in diabetic cohort. The model incorporating CT-FFR, LAP and HbA1c yielded excellent performance in predicting MACE.

Study context

Population
Diabetic patients with intermediate pre-test probability of CAD referred for coronary CT angiography, followed ≥2 years; mean age 61.0 ± 7.0 years, 1031 malestraining cohort 957
Participants
1,797 patients
Exposure
Model with computed tomography fractional flow reserve (CT-FFR) (model2) vs model with clinical and conventional imaging parameters (model1)
Outcome
MACE
Follow-up
At least 2 years
Methodological detailsprognostic model development, internal validation, independent external test cohort
  • Prognostic model development
  • Internal validation
  • Independent external test cohort

Main finding

As reported in the abstract

Prediction of MACE (C-index), training cohort

model2

0.82

C-index · interval 0.77–0.87

model1

0.80

C-index · interval 0.75–0.85

model2 vs model1: P = 0.021 · model2 vs model1: P < 0.001

Major adverse cardiac event (MACE) incidence during follow-up
7.18% (129/1797)
Independent predictor of MACE: CT-FFR ≤ 0.80, HR
4.534 (p < 0.001)
Independent predictor of MACE: HbA1c, HR
1.142 (p = 0.015)
Independent predictor of MACE: low attenuation plaque, HR
3.973 (p = 0.041)

Observational data: associations, not effects.

Further findings

Model performance in internal validation (n=411) and external test (n=429) cohorts

Similar findings in internal validation and external test cohorts

Original publication

CT-derived fractional flow reserve for prediction of major adverse cardiovascular events in diabetic patients. Cardiovasc Diabetol. Published 21 March 2023. doi:10.1186/s12933-023-01801-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.